| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $669.5M | $510.9M | $413.0M |
| YoY Revenue Growth % | +31.0% | +23.7% | — |
| Gross Profit | $153.8M | $128.7M | — |
| Gross Margin % | 23.0% | 25.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$151.3M | -$58.5M | -$74.2M |
| Operating Margin % | -22.6% | -11.5% | -18.0% |
| Net Income (GAAP) | -$111.6M | -$63.0M | -$85.5M |
| EBITDA (Normalized) | -$133.8M | -$48.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $86.4M | $81.9M | $14.9M |
| Capital Expenditures (CapEx) | $21.9M | $12.3M | — |
| Free Cash Flow (FCF) | $64.5M | $69.6M | $14.9M |
| FCF Margin % | 9.6% | 13.6% | 3.6% |
| Return on Invested Capital (ROIC %) | -26.9% | -10.0% | — |
| Cash & Short-Term Equivalents | $280.6M | $110.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $724.5M | $572.4M | — |